Search

everythinglearnresearchcommunity

for

Search:↓

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Dutasteride reduces DHT more effectively than finasteride.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.

Doxazosin alone or combined with finasteride improves prostate symptoms better than finasteride alone, without extra benefits.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Trichoscopy helps tell different hair loss types apart using specific scalp and hair patterns.

Baldness (androgenic alopecia) could be a risk factor for prostate cancer.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Early balding may be a sign of future prostate problems.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Finasteride is effective for male hair loss, but it may cause fertility issues, mental health problems, and rarely, breast growth. Regular health checks can reduce the risk of prostate cancer. Patient understanding and involvement in treatment is important.

Higher serum androgens contribute to male pattern baldness.

There is no link between hair loss and prostate enlargement.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Hair loss can be an early sign of prostate enlargement.

Researchers created a simple tool to predict bladder blockage from prostate enlargement using urine flow rate and prostate volume.

St. John's Wort may reduce the effectiveness of finasteride by increasing its breakdown in the body.